Prevalence of diabetes and diabetic macular edema in patients undergoing senile cataract surgery in Italy: The DIabetes and CATaract study.
Aged
Cataract
/ complications
Cataract Extraction
/ statistics & numerical data
Cross-Sectional Studies
Diabetes Mellitus
/ epidemiology
Diabetic Retinopathy
/ epidemiology
Female
Glycated Hemoglobin
/ analysis
Humans
Italy
/ epidemiology
Macular Edema
/ epidemiology
Male
Middle Aged
Phacoemulsification
/ adverse effects
Prevalence
Prospective Studies
Tomography, Optical Coherence
Visual Acuity
Diabetes
cataract
cataract surgery
diabetic macular edema
diabetic retinopathy
phacoemulsification
Journal
European journal of ophthalmology
ISSN: 1724-6016
Titre abrégé: Eur J Ophthalmol
Pays: United States
ID NLM: 9110772
Informations de publication
Date de publication:
Mar 2020
Mar 2020
Historique:
pubmed:
12
3
2019
medline:
24
3
2020
entrez:
12
3
2019
Statut:
ppublish
Résumé
The purpose of this study is to determine the prevalence of diabetes and diabetic macular edema in patients undergoing senile cataract surgery in Italy. It is a prospective, multicenter, cross-sectional study. Thirteen ophthalmic units equally distributed across the Italian territory have been involved in the study. For a period of 3 months, all subjects undergoing phacoemulsification received an Optical Coherence Tompgraphy (OCT) scan and were screened for the anamnestic presence of diabetes. In addition, five selected units collected blood samples from all their patients to measure glycated hemoglobin (HbA1c) levels and detect the presence of occult diabetes (HbA1c > 6.5%). In diabetic patients, levels of retinopathy were measured and diabetic macular edema was considered significant (clinically significant macular edema) when foveal thickness was above 30% of normal levels. A total number of 3657 subjects have been screened. Among them, 20.4% were diabetics. Prevalence of diabetes was significantly higher in males (24.7%) than in females (17%). Levels of HbA1c were tested in a representative sample of 1216 consecutive subjects, and occult diabetes was diagnosed in 4.8% of cases. No significant differences were observed between age groups or different geographic areas. Among diabetic patients, diabetic macular edema of any kind was present in 27.5% (clinically significant macular edema (6.6%)). No significant differences were seen in the prevalence of diabetic macular edema between males and females or between age groups. Among the 745 diabetic patients, no signs of retinopathy were seen in 537 subjects (76.3%), while 101 patients (14.3%) had nonproliferative retinopathy, 13 (1.7%) had nontreated proliferative diabetic retinopathy, and 53 (7.5%) had laser-treated retinopathy. In the entire sample of 3657 subjects, a normal macula was present in 90.9% of cases, diabetic macular edema of any kind in 5.4%, and other maculopathies in 3.4%. In this large cohort study on patients undergoing cataract surgery, more than one-fourth were diabetics and more than one-fourth of these had diabetic macular edema. These high prevalences suggest the opportunity to plan an adequate preoperative assessment in all patients in order to reduce the risk of postoperative development or worsening of a sight-threatening complication such as chronic diabetic macular edema.
Sections du résumé
BACKGROUND
BACKGROUND
The purpose of this study is to determine the prevalence of diabetes and diabetic macular edema in patients undergoing senile cataract surgery in Italy.
METHODS
METHODS
It is a prospective, multicenter, cross-sectional study. Thirteen ophthalmic units equally distributed across the Italian territory have been involved in the study. For a period of 3 months, all subjects undergoing phacoemulsification received an Optical Coherence Tompgraphy (OCT) scan and were screened for the anamnestic presence of diabetes. In addition, five selected units collected blood samples from all their patients to measure glycated hemoglobin (HbA1c) levels and detect the presence of occult diabetes (HbA1c > 6.5%). In diabetic patients, levels of retinopathy were measured and diabetic macular edema was considered significant (clinically significant macular edema) when foveal thickness was above 30% of normal levels.
RESULTS
RESULTS
A total number of 3657 subjects have been screened. Among them, 20.4% were diabetics. Prevalence of diabetes was significantly higher in males (24.7%) than in females (17%). Levels of HbA1c were tested in a representative sample of 1216 consecutive subjects, and occult diabetes was diagnosed in 4.8% of cases. No significant differences were observed between age groups or different geographic areas. Among diabetic patients, diabetic macular edema of any kind was present in 27.5% (clinically significant macular edema (6.6%)). No significant differences were seen in the prevalence of diabetic macular edema between males and females or between age groups. Among the 745 diabetic patients, no signs of retinopathy were seen in 537 subjects (76.3%), while 101 patients (14.3%) had nonproliferative retinopathy, 13 (1.7%) had nontreated proliferative diabetic retinopathy, and 53 (7.5%) had laser-treated retinopathy. In the entire sample of 3657 subjects, a normal macula was present in 90.9% of cases, diabetic macular edema of any kind in 5.4%, and other maculopathies in 3.4%.
CONCLUSION
CONCLUSIONS
In this large cohort study on patients undergoing cataract surgery, more than one-fourth were diabetics and more than one-fourth of these had diabetic macular edema. These high prevalences suggest the opportunity to plan an adequate preoperative assessment in all patients in order to reduce the risk of postoperative development or worsening of a sight-threatening complication such as chronic diabetic macular edema.
Identifiants
pubmed: 30854895
doi: 10.1177/1120672119830578
pmc: PMC7079292
doi:
Substances chimiques
Glycated Hemoglobin A
0
Types de publication
Journal Article
Multicenter Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
315-320Références
Ophthalmology. 2016 Feb;123(2):316-323
pubmed: 26681390
J Cataract Refract Surg. 2012 Jun;38(6):1086-93
pubmed: 22541829
Lancet Glob Health. 2013 Dec;1(6):e339-49
pubmed: 25104599
Ophthalmology. 2007 May;114(5):881-9
pubmed: 17275910
Br J Ophthalmol. 2012 May;96(5):614-8
pubmed: 22133988
Diabetes Res Clin Pract. 2014 Feb;103(2):206-17
pubmed: 24300019
CMAJ. 2011 Oct 4;183(14):1621
pubmed: 21825045
Am J Ophthalmol. 1998 Dec;126(6):782-90
pubmed: 9860001
Insight. 2014 Spring;39(2):18-20
pubmed: 24847564
Ophthalmology. 1985 Sep;92(9):1191-6
pubmed: 4058882
J Cataract Refract Surg. 2003 May;29(5):998-1004
pubmed: 12781289
Eye (Lond). 2009 Jan;23(1):38-49
pubmed: 18034196
Diabetes Metab. 2013 May;39(3):271-5
pubmed: 23628550
Am J Public Health. 2012 Aug;102(8):1482-97
pubmed: 22698044
Acta Ophthalmol. 2011 Aug;89(5):e434-8
pubmed: 21457484
Am J Ophthalmol. 2016 Nov;171:130-138
pubmed: 27615607
Eye (Lond). 2018 Jun;32(6):1028-1035
pubmed: 29386666
J Ophthalmol. 2010;2010:608751
pubmed: 20634936